The increase in IGFBP-3 concentration, which could be a result of an inflammatory response to brain degeneration [105], may reduce bioavailable IGF-1 in the AD brain, further reducing the amount of bioavailable IGF-1. Here, IGFBP3 is linked to Alzheimer disease.